Live Analyst Rating Changes 21422 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Grossman
STIF

David Grossman

Stifel Nicolaus
Wall Street Analyst
★★★★☆
#410
on 13Foresight · ranked by our own returns
64%
Success Rate
+6.9%
Average Return
30 of 47 calls profitable · +3.8% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 64% of David Grossman's ratings turned a profit when each position was held for 1 year — averaging +6.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

80 Buy 50 Hold 0 Sell
David's Stock Coverage 19 ratings · 2026-08-09
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
HCAT
Health Catalyst
 Aug 07, 2026 HOLD Buy
+225.0% avg upside
15 analysts
$2.00
15.59% Upside
 +0.0% ·
EPAM
Epam Systems
 Aug 06, 2026 BUY Strong Buy
+72.8% avg upside
28 analysts
$135.00
38.48% Upside
 +4.7% ·
HNGE
Hinge Health, Inc. Class A
 Aug 05, 2026 BUY Strong Buy
+5.2% avg upside
17 analysts
$96.00
7.47% Upside
 +10.6% ·
AMWL
American Well
 Aug 05, 2026 HOLD Buy
+5.6% avg upside
15 analysts
$11.00
18.66% Downside
 +0.0% ·
ADP
Automatic Data Processing
 Aug 03, 2026 HOLD Hold
-8.4% avg upside
28 analysts
$285.00
4.96% Upside
 +0.6% ·
DXC
DXC Technology
 Jul 31, 2026 HOLD Hold
+150.5% avg upside
22 analysts
$10.50
3.11% Downside
 -1.1% ·
TNET
TriNet Group
 Jul 31, 2026 BUY Buy
-11.8% avg upside
13 analysts
$82.00
19.68% Upside
 +3.9% ·
TDOC
Teladoc
 Jul 30, 2026 HOLD Buy
+306.6% avg upside
38 analysts
$5.50
22.88% Downside
 +8.4% ·
EXLS
Exlservice Holdings
 Jul 29, 2026 BUY Strong Buy
+31.3% avg upside
13 analysts
$46.00
31.86% Upside
 -3.1% ·
INFY
Infosys
 Jul 24, 2026 HOLD Buy
+47.4% avg upside
22 analysts
$13.00
3.84% Upside
 +11.2% ·
IBM
International Business Machines
 Jul 23, 2026 BUY Buy
-4.1% avg upside
42 analysts
$235.00
0.96% Downside
 +14.8% ·
PAYX
Paychex
 Jun 21, 2026 HOLD Hold
-11.9% avg upside
27 analysts
$110.00
8.45% Downside
 +26.5% ·
ACN
Accenture
 Jun 21, 2026 BUY Strong Buy
+22.7% avg upside
42 analysts
$225.00
27.98% Upside
 +42.5% ·
VEEV
Veeva Systems
 Jun 04, 2026 BUY Buy
+3.8% avg upside
37 analysts
$230.00
0.24% Downside
 +29.0% ·
DRIO
DarioHealth
 May 15, 2026 BUY Strong Buy
+16.5% avg upside
5 analysts
$10.00
37.06% Upside
 -12.0% ·
OPRX
OptimizeRx
 May 13, 2026 BUY Strong Buy
+81.8% avg upside
9 analysts
$14.00
97.66% Upside
 +43.9% ·
DCGO
DocGo
 May 12, 2026 BUY Buy
+329.6% avg upside
7 analysts
$2.50
294.12% Upside
 +5.0% ·
DH
Definitive Healthcare Corp
 Feb 27, 2026 BUY Hold
+683.5% avg upside
19 analysts
$3.00
320.46% Upside
 -44.5% ·
CSCO
Cisco Systems
 Aug 07, 2013 BUY Strong Buy
-23.4% avg upside
46 analysts
$58.00
52.23% Downside
 -1.9% ·
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David Grossman — Frequently Asked Questions
How accurate are David Grossman's stock ratings?
Based on the calls 13Foresight could measure, about 64% of David's ratings were profitable over a one-year hold, with an average return of +6.9% per rating, or +3.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is David ranked on 13Foresight?
David Grossman is currently ranked #410 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on HCAT, EPAM, HNGE, AMWL, ADP, DXC, TNET, TDOC, EXLS, INFY, IBM, PAYX and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.